Inhibition of histone methyltransferase PRMT5 attenuates cisplatin-induced hearing loss through the PI3K/Akt-mediated mitochondrial apoptotic pathway

This study aimed to evaluate the therapeutic potential of inhibiting protein arginine methyltransferase 5 (PRMT5) in cisplatin-induced hearing loss. The effects of PRMT5 inhibition on cisplatin-induced auditory injury were determined using immunohistochemistry, apoptosis assays, and auditory brainstem response. The mechanism of PRMT5 inhibition on hair cell survival was assessed using RNA-seq and Cleavage Under Targets and Tagment-quantitative polymerase chain reaction (CUT&Tag-qPCR) analyses in the HEI-OC1 cell line. Pharmacological inhibition of PRMT5 significantly alleviated cisplatin-induced damage to hair cells and spiral ganglion neurons in the cochlea and decreased apoptosis by protecting mitochondrial function and preventing the accumulation of reactive oxygen species. CUT&Tag-qPCR analysis demonstrated that inhibition of PRMT5 in HEI-OC1 cells reduced the accumulation of H4R3me2s/H3R8me2s marks at the promoter region of the Pik3ca gene, thus activating the expression of Pik3ca. These findings suggest that PRMT5 inhibitors have strong potential as agents against cisplatin-induced ototoxicity and can lay the foundation for further research on treatment strategies of hearing loss.

• Publication year

  2023

• Venue

  Journal of Pharmaceutical Analysis

• Publication date

  2023-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.jpha.2023.04.014PMID 37440906PMCID 10334280
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• PRMT5-mediated arginine methylation activates AKT kinase to govern tumorigenesis

  2021cited by this paper
• Inhibition of Protein arginine methyltransferase 6 reduces reactive oxygen species production and attenuates aminoglycoside- and cisplatin-induced hair cell death

  2020cited by this paper
• Targeting PRMT5 Activity Inhibits the Malignancy of Hepatocellular Carcinoma by Promoting the Transcription of HNF4α

  2019cited by this paper
• CUT&Tag for efficient epigenomic profiling of small samples and single cells

  2019cited by this paper
• Inhibition of PRMT5 Attenuates Oxidative Stress-Induced Pyroptosis via Activation of the Nrf2/HO-1 Signal Pathway in a Mouse Model of Renal Ischemia-Reperfusion Injury

  2019cited by this paper
• LLY-283, a Potent and Selective Inhibitor of Arginine Methyltransferase 5, PRMT5, with Antitumor Activity.

  2018cited by this paper
• Inhibition of protein arginine methyltransferase 5 enhances hepatic mitochondrial biogenesis

  2018cited by this paper
• CAPG enhances breast cancer metastasis by competing with PRMT5 to modulate STC-1 transcription

  2018cited by this paper
• Recent progress in developing selective inhibitors of protein methyltransferases.

  2017cited by this paper
• Arginine Methylation: The Coming of Age.

  2017cited by this paper
• AKT/PKB Signaling: Navigating the Network.

  2017cited by this paper
• Potent, Selective, and Cell Active Protein Arginine Methyltransferase 5 (PRMT5) Inhibitor Developed by Structure-Based Virtual Screening and Hit Optimization.

  2017cited by this paper
• The PAF Complex Regulation of Prmt5 Facilitates the Progression and Maintenance of MLL-Fusion Leukemia

  2017cited by this paper
• Histone deacetylase 1 is required for the development of the zebrafish inner ear

  2016cited by this paper
• HDAC3 Is Required for Posterior Lateral Line Development in Zebrafish

  2016cited by this paper
• Small Molecule Inhibitors of Protein Arginine Methyltransferases

  2016cited by this paper
• A TGFβ-PRMT5-MEP50 Axis Regulates Cancer Cell Invasion through Histone H3 and H4 Arginine Methylation Coupled Transcriptional Activation and Repression

  2016cited by this paper
• Epigenetic regulation of Atoh1 guides hair cell development in the mammalian cochlea

  2016cited by this paper
• Targeting methyltransferase PRMT5 eliminates leukemia stem cells in chronic myelogenous leukemia.

  2016cited by this paper
• Protein arginine methyltransferase 5 is associated with malignant phenotype and peritoneal metastasis in gastric cancer.

  2016cited by this paper
• The epigenetic modifier DNMT3A is necessary for proper otic placode formation.

  2016cited by this paper
• Structure and Property Guided Design in the Identification of PRMT5 Tool Compound EPZ015666.

  2016cited by this paper
• Promoter–enhancer looping at the PPARγ2 locus during adipogenic differentiation requires the Prmt5 methyltransferase

  2016cited by this paper
• The PRMT5 arginine methyltransferase: many roles in development, cancer and beyond

  2015cited by this paper
• Epigenetic regulation of Atoh1 guides hair cell development in the mammalian cochlea

  2015cited by this paper
• Arginine methyltransferase PRMT5 is essential for sustaining normal adult hematopoiesis.

  2015cited by this paper
• Auditory hair cell defects as potential cause for sensorineural deafness in Wolf-Hirschhorn syndrome

  2015cited by this paper
• Inhibition of H3K4me2 Demethylation Protects Auditory Hair Cells from Neomycin-Induced Apoptosis

  2015cited by this paper
• Histone demethylase KDM4B regulates otic vesicle invagination via epigenetic control of Dlx3 expression

  2015cited by this paper
• A selective inhibitor of PRMT5 with in vivo and in vitro potency in MCL models.

  2015cited by this paper
• PRMT5 is Required for Human Embryonic Stem Cell Proliferation But Not Pluripotency

  2014cited by this paper
• Role of histone deacetylase activity in the developing lateral line neuromast of zebrafish larvae

  2014cited by this paper
• PRMT5 dimethylates R30 of the p65 subunit to activate NF-κB

  2013cited by this paper
• Protein arginine methyl transferases‐3 and ‐5 increase cell surface expression of cardiac sodium channel

  2013cited by this paper
• Inhibition of H3K9 methyltransferases G9a/GLP prevents ototoxicity and ongoing hair cell death

  2013cited by this paper
• Regulation of constitutive and alternative splicing by PRMT5 reveals a role for Mdm4 pre-mRNA in sensing defects in the spliceosomal machinery

  2013cited by this paper
• Trans-2-phenylcyclopropylamine regulates zebrafish lateral line neuromast development mediated by depression of LSD1 activity.

  2013cited by this paper
• Activation of PRMT1 and PRMT5 mediates hypoxia- and ischemia-induced apoptosis in human lung epithelial cells and the lung of miniature pigs: the role of p38 and JNK mitogen-activated protein kinases.

  2013cited by this paper
• Regulation of mitochondrial respiration and apoptosis through cell signaling: cytochrome c oxidase and cytochrome c in ischemia/reperfusion injury and inflammation.

  2012cited by this paper
• Arginine methylation controls growth regulation by E2F‐1

  2012cited by this paper
• Transcription Factor Positive Regulatory Domain 4 (PRDM4) Recruits Protein Arginine Methyltransferase 5 (PRMT5) to Mediate Histone Arginine Methylation and Control Neural Stem Cell Proliferation and Differentiation*

  2012cited by this paper
• Functions of DNA methylation: islands, start sites, gene bodies and beyond

  2012cited by this paper
• Versatility of PRMT5-induced methylation in growth control and development.

  2011cited by this paper
• Protein Arginine Methyltransferase 5 (PRMT5) Signaling Suppresses Protein Kinase Cδ- and p38δ-dependent Signaling and Keratinocyte Differentiation*

  2011cited by this paper
• The histone- and PRMT5-associated protein COPR5 is required for myogenic differentiation

  2011cited by this paper
• Methylation of Ribosomal Protein S10 by Protein-arginine Methyltransferase 5 Regulates Ribosome Biogenesis*

  2010cited by this paper
• Application of machine learning methods to histone methylation ChIP-Seq data reveals H4R3me2 globally represses gene expression

  2010cited by this paper
• Prmt5 is essential for early mouse development and acts in the cytoplasm to maintain ES cell pluripotency.

  2010cited by this paper
• Distinct Protein Arginine Methyltransferases Promote ATP-Dependent Chromatin Remodeling Function at Different Stages of Skeletal Muscle Differentiation

  2009cited by this paper
• PRMT5, a Novel TRAIL Receptor-Binding Protein, Inhibits TRAIL-Induced Apoptosis via Nuclear Factor-κB Activation

  2009cited by this paper
• Methylation of histone H3 and H4 by PRMT5 regulates ribosomal RNA gene transcription

  2009cited by this paper
• PRMT 5 , a Novel TRAIL Receptor-Binding Protein , Inhibits TRAIL-Induced Apoptosis via Nuclear Factor-κ B Activation

  2009cited by this paper
• A histone H3 lysine 36 trimethyltransferase links Nkx2-5 to Wolf–Hirschhorn syndrome

  2009cited by this paper
• Arginine methylation regulates the p53 response

  2008cited by this paper
• Role of the mitochondrial membrane permeability transition in cell death

  2007cited by this paper
• Chromatin modifications and their function.

  2007cited by this paper
• Low levels of miR‐92b/96 induce PRMT5 translation and H3R8/H4R3 methylation in mantle cell lymphoma

  2007cited by this paper
• The Protein Arginine Methyltransferase Prmt5 Is Required for Myogenesis because It Facilitates ATP-Dependent Chromatin Remodeling

  2006cited by this paper
• Human PRMT5 Expression Is Enhanced during in vitro Tubule Formation and after in vivo Ischemic Injury in Renal Epithelial Cells

  2004cited by this paper
• Negative regulation of transcription by the type II arginine methyltransferase PRMT5

  2002cited by this paper
• Chromatin Modifications and Their Function

  year unknowncited by this paper

• Mitochondrial acetyl-CoA reprogramming by the SIRT3–ACSS2–OPA1 axis confers resistance to ferroptosis in Parkinson's disease

  2026cites this paper
• Unraveling the mechanisms of Phillyrin’s otoprotective effects: An integrated approach of network pharmacology and in vitro validation

  2026cites this paper
• Epigenetic Modifications in Sensorineural Hearing Loss: Protective Mechanisms and Therapeutic Potential

  2025cites this paper
• MLL1 downregulation drives hair cell ferroptosis via mitochondrial and endoplasmic reticulum stress mechanisms through PERK-eIF2α-Atf4-Chop and PI3K/Akt-Lrp1 signaling pathway.

  2025cites this paper
• Comparative Cochlear Transcriptomics in Echolocating Bats and Mouse Reveals Hras as Protector Against Noise‐Induced Hearing Loss

  2025cites this paper
• Polyphenolic compounds as protective agents against cisplatin-induced ototoxicity with molecular mechanisms and clinical potential.

  2025cites this paper
• Network Pharmacology and Molecular Docking Elucidate the Mechanism of Phillyrin in Colorectal Cancer

  2025cites this paper
• Atomically dispersed copper(I) on tungstosilicic acid for catalytic protection against cisplatin-induced hearing loss.

  2025cites this paper
• Sotorasib-impaired degradation of NEU1 contributes to cardiac injury by inhibiting AKT signaling

  2025cites this paper
• Ferritin-based targeted delivery of cimifugin to hair cells provides strong protection against hearing loss

  2025cites this paper
• Leonurine protects against cisplatin-induced ototoxicity through its anti-oxidation and anti-apoptosis properties.

  2025cites this paper
• Mitochondria-Targeting Virus-Like Gold Nanoparticles Enhance Chemophototherapeutic Efficacy Against Pancreatic Cancer in a Xenograft Mouse Model

  2024cites this paper
• Apoptosis, autophagy, ferroptosis, and pyroptosis in cisplatin-induced ototoxicity and protective agents

  2024cites this paper
• Trace elements and metal nanoparticles: mechanistic approaches to mitigating chemotherapy-induced toxicity—a review of literature evidence

  2024cites this paper
• Oxidative Damage as a Fundament of Systemic Toxicities Induced by Cisplatin—The Crucial Limitation or Potential Therapeutic Target?

  2023cites this paper